However, the STAT3 pathway has been shown to be a potent regulator of the hypoxic pathway [20] and our in vivo data suggests that AZD1480 may circumvent the induction of hypoxia - a known mediator of treatment resistance to multiple cancer therapies. Here, STAT3 is linked to cancer.